Reig Jofre invests €5.8 million in Leanbio for vertical integration in biotechnology. They increase their stake to 24%, committing to expanding further. The collaboration aims to...
Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...
In the Spanish biotech sector, 60% of employees are women, yet only 37% of leadership positions in companies are held by women, according to a report...
There are also signs to anticipate the entry into a consolidation phase of the digital health business. The merger and acquisition (M&A) of companies in this...
The path laid out by general pharmaceutical legislation, according to the Asebio study's conclusions, makes it less likely to achieve objectives related to, for example, rare...
One of the challenges is to achieve greater financial support for research so that it can be carried out in a stable manner. Precisely to help...
Werfen is chaired by Marc Rubiralta and in 2022 it achieved a turnover of 1.84 billion. In the largest operation in its history, the group closed...
Genesis Biomed's position in Valencia is backed by its experience in the field of technology transfer and early-stage biomedical projects in the region, having worked for universities (UPV, UV,...
Ship2B launched its first investment vehicle in 2016, with €4.5 million, investing in 23 companies of which they have already divested from three companies. In 2020, the...
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...